918博天娱乐·(中国)官方网站
Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(华堂宁®)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
中
繁
中
繁
中
Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(华堂宁®)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
Investor Relations
>
Investor Relations
>
Announcements and Circulars
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Announcements and Circulars
Search
Mar 07, 2019
Grant of Share Options
Read More
Mar 07, 2019
Annual Results Announcement For The Year Ended December 31, 2018
Read More
Mar 07, 2019
Change Of Company Secretary And Authorised Representative
Read More
Mar 05, 2019
Monthly Return
Read More
Mar 01, 2019
Business Update Completion Of Patient Enrollment For Phase III Monotherapy Trial Of Dorzagliatin
Read More
Feb 26, 2019
Date of Board Meeting
Read More
Feb 20, 2019
Board Diversity Policy
Read More
Feb 01, 2019
Monthly Return
Read More
Feb 01, 2019
VOLUNTARY ANNOUNCEMENT FIRST COMBINATION STUDY OF DORZAGLIATIN WITH A DPP-4 INHIBITOR IN THE UNITED STATES
Read More
Jan 03, 2019
Monthly Return
Read More
Jan 01, 2019
Grant of Share Options
Read More
Dec 07, 2018
Monthly Return
Read More
<<
<
9
10
11
12
13
14
15
16
17
18
19
>
>>
上一页
下一页
About Us
Company Overview
Company History
Leadership Team
Portfolio Advisory Board
Senior Scientific Advisory Board
Partner
Media center
Research & Development
Inovation
Pipeline
Dorzagliatin
mGluR5
Company Publications
Peer Reviewed Publications
Investor Relations
Corporate Governance
Financial Report
Announcements & Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock information
Media
Company News
Media Releases
Video
Careers
Culture
Join Us
Product
HuaTangNing(华堂宁®)
Subscribe Email
Focus Us
Copyright © 2024 Hua Medicine (Shanghai) Co., Ltd. 互联网药品信息服务资格证书编号: (沪)-非经营-2022-0079
沪ICP备14036654号-1
沪公网安备 31011502013809号
Privacy Statement
Terms of Use
Search
How we use cookies
Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our
privacy statement
.
Accept
x
友情链接:
澳门人威尼斯3966
尊龙凯时 - 人生就是搏!
尊龙凯时 - 人生就是搏!
尊龙凯时·(中国区)人生就是搏!
澳门人威尼斯3966